![]() |
|
|
Vol. 300, Issue 1, 142-148, January 2002
-Glutamyl Transpeptidase or Cysteine
S-Conjugate
-Lyase Activity Blocks the Nephrotoxicity
of Cisplatin in Mice
Department of Cell Biology, University of Virginia,
Charlottesville, Virginia (D.M.T.); and Department of Cell Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
(M.H.H.)
Cisplatin is nephrotoxic. The mechanism underlying this
organ-specific toxicity is unknown. We hypothesize that cisplatin is
metabolized via a
-glutamyl transpeptidase (GGT) and cysteine S-conjugate
-lyase-dependent pathway that has been
shown to activate several haloalkenes to nephrotoxins. To test this
hypothesis, we inhibited GGT and cysteine S-conjugate
-lyase in C57BL/6 mice and analyzed the effect of the inhibitors on
the nephrotoxicity of cisplatin. GGT was inhibited by pretreating the
mice with acivicin. Cysteine S-conjugate
-lyase was
inhibited by aminooxyacetic acid (AOAA). Male C57BL/6 mice were treated
with 15 mg/kg cisplatin (i.p.) and sacrificed on day 5. Half the mice
treated with cisplatin alone died before sacrifice. The
cisplatin-treated mice sacrificed at 5 days had significantly elevated
levels of blood urea nitrogen (BUN). Histologic analysis revealed
severe damage to the renal proximal tubules. Pretreatment with acivicin
or AOAA protected the mice from the nephrotoxicity of cisplatin. None
of the pretreated animals died before sacrifice. BUN levels and
quantitative histologic analysis of the kidneys confirmed the
protective effect of acivicin and AOAA. Platinum levels in the kidneys
were not altered by acivicin or AOAA, indicating that neither affected
the uptake of cisplatin into the kidney. Likewise, cisplatin-induced
weight loss was not altered by acivicin or AOAA, suggesting that weight
loss and nephrotoxicity are via distinct mechanisms. These data support
the hypothesis that the nephrotoxicity of cisplatin is due to the
metabolism of a platinum-glutathione conjugate by GGT and cysteine
S-conjugate
-lyase to a potent nephrotoxin.
This article has been cited by other articles:
![]() |
M. H. Hanigan, M. Deng, L. Zhang, P. T. Taylor Jr., and M. G. Lapus Stress response inhibits the nephrotoxicity of cisplatin Am J Physiol Renal Physiol, January 1, 2005; 288(1): F125 - F132. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and M. H. Hanigan Role of Cysteine S-Conjugate {beta}-Lyase in the Metabolism of Cisplatin J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 988 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Townsend, J. A. Marto, M. Deng, T. J. Macdonald, and M. H. Hanigan HIGH PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY CHARACTERIZATION OF THE NEPHROTOXIC BIOTRANSFORMATION PRODUCTS OF CISPLATIN Drug Metab. Dispos., June 1, 2003; 31(6): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Townsend, M. Deng, L. Zhang, M. G. Lapus, and M. H. Hanigan Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells J. Am. Soc. Nephrol., January 1, 2003; 14(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||